30 Apr Recommended Calculation of Contraception Duration After Completion of Therapy to Minimise The Risk of Genotoxic Anticancer Medicine-mediated Reproductive Adverse Events
Posted at 11:13h
in
In collaboration with the South African Health Products Regulatory Authority (SAHPRA), the companies listed in the attached document would like to inform you about recommended calculations of contraception duration after completion of therapy with genotoxic anticancer medicines (Including potential genotoxic metabolites).
Download latest version
Document Number:
DHCPL
Version:
1
Date Updated:
29/04/2024
File Type:
pdf
Category:
Communication To Health Care Professionals